Investigating Epstein-Barr Virus Associated Conjunctivitis
Launched by MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST · Nov 13, 2024
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Participants shall be considered eligible for inclusion if:
- • Aged ≥16 years;
- • working diagnosis of infective (viral) follicular conjunctivitis (\<4 weeks duration)
- • EBV positive conjunctival swab
- Exclusion Criteria:
- • • Present with symptoms/signs such that another diagnosis is deemed more likely, for example topical medication-induced conjunctivitis.
- • Participant declines diagnostic tests or appropriate corneal or conjunctival sample(s) not obtained for any reason
About Moorfields Eye Hospital Nhs Foundation Trust
Moorfields Eye Hospital NHS Foundation Trust is a leading specialist eye hospital located in London, renowned for its commitment to advancing ophthalmic research and clinical care. As a prominent clinical trial sponsor, Moorfields is dedicated to improving patient outcomes through innovative research, employing cutting-edge technology and methodologies in the field of ophthalmology. The institution collaborates with a diverse range of partners, including academic institutions and industry stakeholders, to facilitate groundbreaking studies aimed at developing new treatments and therapies for various eye conditions. With a strong focus on patient safety and ethical standards, Moorfields Eye Hospital remains at the forefront of eye care, driving progress in the understanding and management of visual impairments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported